FAST Trial Published: No Benefit of Factor VII in Treatment of ICH
Vendredi 16 Mai 2008 - 09:37 - 7 mois, 3 semaines depuis
-
Presse spécialisée
-
Medscape family medicine
Disappointing phase 3 results failed to confirm promising phase 2b findings, showing that although recombinant activated factor VII reduced hematoma growth in patients with acute intracerebral hemorrhage, it did not improve survival or functional outcome. Medscape Medical News